This landmark Troponin I test is the only high sensitivity, ACC, ESC and AHA guideline-compliant Troponin assay offering true point-of-care capability.
Designed for use with the revolutionary, state-of-the-art Meritas POC Analyzer, the Meritas Troponin I test enables fast, accurate triage and intervention for patients presenting at the emergency department with a possible myocardial infarction (MI), as well as for risk stratification of patients. Results, which are traceable to NIST SRM 2921, are comparable to those obtained using traditional top performing laboratory analyzers, and are available in just 15 minutes. Turnaround times, patient care and outcomes are improved, helping to maximize the use of precious hospital resources and generate significant cost savings. Studies are currently underway to validate the clinical performance of the Meritas Troponin I POC test to obtain CE marking, and additional assays are being developed to extend the test menu further.
*******
Editorial contact for further information or follow-up
Sarah Khan at kdm communications limited, St Neots, UK
Tel. +44 (0)1480 405333 Fax: +44 (0)1480 477833
email ideas@kdm-communications.com
____________________________________________________